Related Experiment Video
Updated: May 29, 2026
12:55
Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
Published on: October 10, 2017
Antimetastatic activity isolated from Colocasia esculenta (taro)
Namita Kundu1, Patricia Campbell, Brian Hampton
1Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland 21201, USA.
Anti-Cancer Drugs
|September 22, 2011
Summary
Taro extract (TE) effectively inhibits breast cancer metastasis in preclinical models by blocking tumor cell migration and reducing prostaglandin E2 synthesis. This novel therapeutic agent shows promise for treating metastatic breast cancer with minimal toxicity.
Area of Science:
- Biochemistry
- Oncology
- Pharmacology
Background:
- Metastatic breast cancer remains a primary cause of mortality.
- Novel therapeutic strategies targeting metastasis are urgently needed.
- Colocasia esculenta (taro) is an edible plant with potential medicinal properties.
Purpose of the Study:
- To investigate the antimetastatic activity of taro extract (TE) in a preclinical model of metastatic breast cancer.
- To identify and characterize the active compounds responsible for the antimetastatic effects.
- To explore the underlying mechanisms of TE's action on cancer cell behavior and signaling pathways.
Main Methods:
- Administration of water-soluble taro extract (TE) to a murine model of highly metastatic triple-negative breast cancer.
- Assessment of lung colonization and spontaneous metastasis.
- In vitro assays evaluating cancer cell proliferation, migration, and morphological changes.
- Analysis of prostaglandin E2 (PGE2) synthesis and cyclooxygenase (COX) mRNA expression.
- Purification and N-terminal amino acid sequencing of active antimetastatic compounds.
Main Results:
- TE significantly inhibited lung metastasis and spontaneous metastasis in vivo.
- TE blocked tumor cell migration and induced morphological changes in vitro.
- TE treatment reduced prostaglandin E2 (PGE2) synthesis and downregulated cyclooxygenase 1 and 2 (COX-1/COX-2) mRNA expression.
- Purified compounds with antimetastatic activity were identified as taro proteins related to 12-kDa storage protein, tarin, and taro lectin.
Conclusions:
- Taro extract (TE) possesses potent antimetastatic properties against aggressive breast cancer.
- The active compounds in TE appear to function by inhibiting tumor cell migration and modulating PGE2/COX pathways.
- Taro-derived compounds represent a promising, low-toxicity therapeutic avenue for combating breast cancer metastasis.
Related Concept Videos
01:15Drugs that Stabilize Microtubules
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...